Poland joins the global TOP 10 in clinical research

According to the latest MedExpress report, in 2024 more than 26,800 patients in Poland took part in clinical trials. This achievement has placed our country among the TOP 10 clinical research markets worldwide — a clear sign that Poland is becoming an increasingly important hub for the development of modern therapies.
(Source: MedExpress.pl)

At Bio Research Group, we are proud to contribute to this growth — creating a space where science, sponsors, and patients come together to drive medical innovation.

For pharmaceutical and biotechnology companies

We are a trusted partner that bridges scientific expertise with clinical experience.
Our strengths include:

  • state-of-the-art infrastructure,

  • experienced and multidisciplinary research teams,

  • transparent procedures and full compliance with international standards (GCP and global regulatory requirements).

For patients

We are a place where people can actively contribute to the advancement of medicine — while being assured of safety, professional care, and an individual approach. Participation in a clinical trial with us means becoming part of a mission that changes lives.

For sponsors

We provide reliability, quality, and efficiency at every stage of the research process. Our goal is to deliver trusted results through responsible clinical practice — building long-term partnerships based on mutual commitment and excellence.

At BRG, we believe that clinical research is not only about data and technology.
It is, above all, about people — their trust, dedication, and shared mission to improve quality of life.

Go back

News

Clinical research reshapes nicotine regulation - BRG article in ITJ

upcoming publication by Dr. Katarzyna Jarus-Dziedzic, on the increasing importance of clinical studies in the Tobacco Market

Read more …

Data Quality at the Center of Regulatory Attention – the BRG Standard

In recent months, regulators have placed an even stronger emphasis on data quality in clinical trials.

Read more …

Regulatory change across the European Union

Flavoured heated tobacco (HnB) sticks withdrawn from sale as of 18 January 2025

Read more …

Novel Nicotine Products Under Increasing Regulatory Pressure. Safety Studies Become a Key Pillar

Novel Nicotine Products Under Increasing Regulatory Pressure. Safety Studies Become a Key Pillar of Market Authorization

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2026 © Bio Research Group. All rights reserved.

 

scroll to top ▲